What’s new in the Academy
Every new chapter, evidence update and correction is logged here first, updated each release weekend. Members also get the highlights in our email digest. Looking for a topic? Pick any course from the course list to see every chapter.
Last updated: 6 Nov 2026Courses released or updated
- New course Managing Anxiolytic & Hypnotic Adverse Events
All 17 chapters in 6 sections are live, including a quick-reference grid. Benzodiazepine overdose, withdrawal and tapering, dementia and fall risk in older adults, complex sleep behaviors on Z-drugs, orexin antagonists, and the other anxiolytics and hypnotics. For members.
- New issue The Fine Print, Issue 2: Lamotrigine, Breastfeeding & Child Development
A JAMA Network Open 2026 cohort followed children of mothers on antiseizure drugs to age 6 (peer-reviewed). What it can and can’t tell you about breastfeeding on lamotrigine, and why it says almost nothing about valproate or lithium. For members.
Free to read: The Fine Print, Issue 1: Escitalopram, QTc & Age
- New course Genetic Testing in Psychiatry
9 chapters in 4 sections plus a one-screen drug–gene action grid. Whether to order a panel, how to read a report a patient hands you, when a metabolizer result changes a dose or a drug, and which results to ignore.
Free to read: Should you order a pharmacogenomic panel? · Should an MTHFR result change treatment?
- Course complete Managing Mood Stabilizer Adverse Events
All 21 chapters in 6 sections are live. Sections 3–6 (valproate, lamotrigine, carbamazepine & oxcarbazepine, and problems shared across mood stabilizers) were released this month.
Free to read: Lithium toxicity · Lithium and declining kidney function · Starting and restarting lamotrigine
Blog posts
- Evidence Watch #4 · Lancet Psychiatry, 2026Your patient’s CYP2D6 type and venlafaxine: who stops it more often?
- Lamotrigine briefYour patient missed lamotrigine for a week: can they restart at the old dose, and why does valproate change the answer?
- Evidence Watch #3 · PLoS Medicine, 2026Antidepressants in pregnancy and the child’s development: does treatment add risk beyond the depression itself?
- Valproate briefWhen should you check ammonia on Depakote, and why don’t normal liver tests and a level in range rule it out?
- New approvalFDA-approved subcutaneous olanzapine LAI: what you need to know vs. Zyprexa Relprevv
Our corrections policy: when we correct a published chapter, it appears under Courses with what changed and why. Spotted something? Tell us through our contact form.
Every chapter is included in Academy membership.
See membership options →